Literature DB >> 9000602

Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p.

I Petersen1, H Langreck, G Wolf, A Schwendel, R Psille, P Vogt, M B Reichel, T Ried, M Dietel.   

Abstract

The genetic mechanisms that define the malignant behaviour of small-cell lung cancer (SCLC) are poorly understood. We performed comparative genomic hybridization (CGH) on 22 autoptic SCLCs to screen the tumour genome for genomic imbalances. DNA loss of chromosome 3p was a basic alteration that occurred in all tumours. Additionally, deletions were observed on chromosome 10q in 94% of tumours and on chromosomes 4q, 5q, 13q and 17p in 86% of tumours. DNA loss was confirmed by loss of heterozygosity (LOH) analysis for chromosomes 3p, 5q and 10q. Simultaneous mutations of these six most abundant genetic changes were found in 12 cases. One single tumour carried at least five deletions. DNA under-representations were observed less frequently on chromosome 15q (55%) and chromosome 16q (45%). The prevalent imbalances were clearly indicated by the superposition of the 22 tumours to a CGH superkaryogram. In our view, the high incidence of chromosomal loss is an indication that SCLC is defined by a pattern of deletions and that the inactivation of multiple growth-inhibitory pathways contributes in particular to the aggressive phenotype of that type of tumour.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9000602      PMCID: PMC2222682          DOI: 10.1038/bjc.1997.13

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  58 in total

1.  Three distinct regions involved in 3p deletion in human lung cancer.

Authors:  K Hibi; T Takahashi; K Yamakawa; R Ueda; Y Sekido; Y Ariyoshi; M Suyama; H Takagi; Y Nakamura; T Takahashi
Journal:  Oncogene       Date:  1992-03       Impact factor: 9.867

2.  Use of non-radioactive detection in SSCP, direct DNA sequencing and LOH analysis.

Authors:  I Petersen; M B Reichel; M Dietel
Journal:  Clin Mol Pathol       Date:  1996-04

3.  Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix.

Authors:  J Yokota; Y Tsukada; T Nakajima; M Gotoh; Y Shimosato; N Mori; Y Tsunokawa; T Sugimura; M Terada
Journal:  Cancer Res       Date:  1989-07-01       Impact factor: 12.701

4.  Dinucleotide repeat polymorphism in the human thyroid hormone receptor beta gene (THRB) on chromosome 3.

Authors:  A Sakurai; G I Bell; L J DeGroot
Journal:  Nucleic Acids Res       Date:  1991-12-11       Impact factor: 16.971

5.  Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung.

Authors:  S Sato; Y Nakamura; E Tsuchiya
Journal:  Cancer Res       Date:  1994-11-01       Impact factor: 12.701

Review 6.  Genetic changes in epithelial solid neoplasia.

Authors:  E Rodriguez; C Sreekantaiah; R S Chaganti
Journal:  Cancer Res       Date:  1994-07-01       Impact factor: 12.701

7.  Frequent novel DNA copy number increase in squamous cell head and neck tumors.

Authors:  P M Brzoska; N A Levin; K K Fu; M J Kaplan; M I Singer; J W Gray; M F Christman
Journal:  Cancer Res       Date:  1995-07-15       Impact factor: 12.701

8.  Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23).

Authors:  J Whang-Peng; C S Kao-Shan; E C Lee; P A Bunn; D N Carney; A F Gazdar; J D Minna
Journal:  Science       Date:  1982-01-08       Impact factor: 47.728

9.  Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization.

Authors:  T Ried; I Petersen; H Holtgreve-Grez; M R Speicher; E Schröck; S du Manoir; T Cremer
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

10.  Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas.

Authors:  M R Speicher; C Howe; P Crotty; S du Manoir; J Costa; D C Ward
Journal:  Cancer Res       Date:  1995-03-01       Impact factor: 12.701

View more
  34 in total

1.  Mapping of the gene for the human telomerase reverse transcriptase, hTERT, to chromosome 5p15.33 by fluorescence in situ hybridization.

Authors:  L A Bryce; N Morrison; S F Hoare; S Muir; W N Keith
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

2.  Genetic imbalances with impact on survival in head and neck cancer patients.

Authors:  U Bockmühl; K Schlüns; I Küchler; S Petersen; I Petersen
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

3.  A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers.

Authors:  Sana Yokoi; Kohichiroh Yasui; Fumiko Saito-Ohara; Katsumi Koshikawa; Toshihiko Iizasa; Takehiko Fujisawa; Takeo Terasaki; Akira Horii; Takashi Takahashi; Setsuo Hirohashi; Johji Inazawa
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

4.  FGFR1 expression and gene copy numbers in human lung cancer.

Authors:  Lukas H Kohler; Masoud Mireskandari; Thomas Knösel; Annelore Altendorf-Hofmann; Almut Kunze; Andreas Schmidt; Norbert Presselt; Yuan Chen; Iver Petersen
Journal:  Virchows Arch       Date:  2012-05-31       Impact factor: 4.064

5.  Unusual sarcomatoid neoplasm of the lung suggesting a myofibrosarcoma.

Authors:  Lars Morawietz; Cornelius Kuhnen; Detlef Katenkamp; Philipp Le Coutre; Axel Ladhoff; Iver Petersen
Journal:  Virchows Arch       Date:  2005-09-13       Impact factor: 4.064

6.  A potential probe set of fluorescence in situ hybridization for detection of lung cancer in bronchial brushing specimens.

Authors:  Yi-Zhen Liu; Zhen Wang; Li-Li Fang; Lu Li; Jian Cao; Xin Xu; Ya-Ling Han; Yan Cai; Liang-Xu Wang; Ming-Rong Wang
Journal:  J Cancer Res Clin Oncol       Date:  2012-04-27       Impact factor: 4.553

7.  Combined MET inhibition and topoisomerase I inhibition block cell growth of small cell lung cancer.

Authors:  Cleo E Rolle; Rajani Kanteti; Mosmi Surati; Suvobroto Nandi; Immanuel Dhanasingh; Soheil Yala; Maria Tretiakova; Qudsia Arif; Todd Hembrough; Toni M Brand; Deric L Wheeler; Aliya N Husain; Everett E Vokes; Ajit Bharti; Ravi Salgia
Journal:  Mol Cancer Ther       Date:  2013-12-10       Impact factor: 6.261

8.  [CGH findings in neuroendocrine tumours of the lung].

Authors:  G Johnen; M Krismann; M Jaworska; K-M Müller
Journal:  Pathologe       Date:  2003-05-15       Impact factor: 1.011

9.  [Small cell lung cancer: pathology and molecular pathology].

Authors:  K Junker; I Petersen
Journal:  Pathologe       Date:  2009-03       Impact factor: 1.011

Review 10.  Small cell lung cancer (SCLC): no treatment advances in recent years.

Authors:  Filippos Koinis; Athanasios Kotsakis; Vasileios Georgoulias
Journal:  Transl Lung Cancer Res       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.